Investors

OraSure Technologies develops, manufactures and markets oral fluid specimen collection devices using proprietary oral fluid technologies, diagnostic products including immunoassays and other in vitro diagnostic tests, and other medical devices. These products are sold in the United States as well as internationally to various clinical laboratories, hospitals, clinics, community-based organizations and other public health organizations, distributors, government agencies, physicians’ offices, and commercial and industrial entities.
More>>
Featured Reports
2013 Annual Report - PDF 2013 Annual Report
OSUR (Common Stock)
ExchangeNASDAQ GS (US Dollar)
Price$10.53
Change (%) Stock is Up 0.73 (7.45%)
Volume2,806,615
Data as of 12/19/14 4:00 p.m. ET
Minimum 20 minute delay
Refresh quote
Recent NewsMore >>
DateTitle 
12/02/14OraSure Technologies Announces 2015 Annual Meeting Date
BETHLEHEM, Pa., Dec. 2, 2014 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (Nasdaq:OSUR) today announced that its 2015 Annual Meeting of Stockholders is scheduled to be held on Monday, May 11, 2015. Further details regarding the meeting will be provided at a later date. About OraSure Technologies OraSure Technologies is a leader in the development, manufacture and distribution of oral fluid diagnostic and collection devices and other technologies designed to detect or diagnose critical ... 
Printer Friendly Version
11/12/14OraSure Technologies to Present at the Canaccord Genuity Medical Technology & Diagnostics Conference
BETHLEHEM, Pa., Nov. 12, 2014 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (Nasdaq:OSUR) today announced that Douglas A. Michels, President and CEO, will speak to the investment community at the Canaccord Genuity Medical Technology & Diagnostic Conference in New York City, New York. The conference will be simultaneously webcast over the Internet. Mr. Michels is scheduled to speak November 20, 2014, at approximately 9:00 AM Eastern Time (6:00 AM Pacific Time). Interested investors can a... 
Printer Friendly Version
11/07/14OraSure Technologies to Present at the Stephens 2014 Fall Investment Conference
BETHLEHEM, Pa., Nov. 7, 2014 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (Nasdaq:OSUR) today announced that Douglas A. Michels, President and CEO, will speak to the investment community at the Stephens 2014 Fall Investment Conference in New York City, New York. The conference will be simultaneously webcast over the Internet. Mr. Michels is scheduled to speak November 12, 2014, at approximately 11:00 AM Eastern Time (8:00 a.m. Pacific Time). Interested investors can access the live webcast... 
Printer Friendly Version
11/05/14OraSure Announces 2014 Third Quarter Financial Results
BETHLEHEM, Pa., Nov. 5, 2014 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (Nasdaq:OSUR), a market leader in oral fluid diagnostics, today announced its consolidated financial results for the three and nine months ended September 30, 2014. Financial Highlights Consolidated net revenues for the third quarter of 2014 were $27.8 million, a 13% increase from the comparable quarter of 2013. Consolidated net revenues for the nine months ended September 30, 2014 were $77.8 million, an 11% ... 
Printer Friendly Version
Upcoming EventsMore >>
DateTitle
05/11/15
OraSure Technologies, Inc. Annual Shareholder Meeting
Quotes delayed at least 15 minutes. Market data provided by Interactive Data.

Terms & Conditions. Powered and implemented by Interactive Data Managed Solutions.



Print Page Print Page | E-mail Page E-mail Page | RSS Feeds RSS Feeds | E-mail Alerts E-mail Alerts | IR Contacts IR Contacts | Financial Tear Sheet Financial Tear Sheet